Zeria Pharmaceutical News

Zeria Pharmaceutical: Notice of conclusion of a marketing and distribution agreement between Tillotts Pharma and Pioneer Pharma in the People's Republic of China

Nov 28 16:00

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2025[Under Japanese GAAP]

Nov 22 14:10

Zeria Pharmaceutical: Summary of Financial Results for the second quarter 2025

Nov 6 15:00

Zeria Pharmaceutical: Notice regarding changes in responsibilities of executive officers

Oct 9 15:00

Zeria Pharmaceutical: Announcement of the new release of “Heparise W Shine”

Oct 1 09:00

Zeria Pharmaceutical: Notice of obtaining approval for manufacture and sale of the drug ZG-801 (Virtasa) for treating hyperkalemia

Sep 24 15:00

Zeria Pharmaceutical: [Delay] The consolidated financial results for the first three months of the fiscal year ending on March 31, 2025 [based on Japanese accounting standards].

Aug 22 09:00

Zeria Pharmaceutical: Overview of Q1 2025 earnings report.

Aug 1 15:00

Zeria Pharmaceutical: Announcements of individual stocks: Development and sales contract for functional dyspepsia treatment using acotiamide hydrochloride hydrate in European, USA, and Canada regions.

Jun 19 12:00

Zeria Pharmaceutical: Announcements of individual stocks regarding the absorption merger (simple merger, abbreviated merger) of a wholly-owned subsidiary.

Jun 13 15:00

Zeria Pharmaceutical: Announcements of individual stocks regarding compliance with listing maintenance criteria.

Jun 4 11:00

Zeria Pharmaceutical: [Delayed] Consolidated Earnings for the Fiscal Year Ended 2024/3/31 [Japanese Accounting Standards]

Jun 3 11:00

Zeria Pharmaceutical: 2024 financial results overview

May 9 15:00

Zeria Pharmaceutical: Notice regarding executive personnel affairs

May 9 15:00

Zeria Pharmaceutical: Notice Concerning Organizational Changes and Executive Personnel

Mar 8 15:15

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024[Japanese GAAP]

Feb 16 12:45

Zeria Pharmaceutical: Summary of Financial Results for the third quarter 2024

Feb 1 15:00

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2024[Japanese GAAP]

Nov 16, 2023 08:30

Zeria Pharmaceutical: Summary of Financial Results for the second quarter 2024

Nov 1, 2023 15:00

Zeria Pharmaceutical: Notice of new releases of “Prevaline Alpha Quick Ointment” and “Prevaline Alpha Quick Cream”

Nov 1, 2023 15:00